President & Chief Executive Officer
Carmine Stengone has served as president, CEO and board member of Contineum Therapeutics since October 2018. Carmine previously served as chief business officer and later as president and CEO of Avelas Biosciences. Before that he served as senior vice president, business development for COI Pharmaceuticals, where he helped co-found five new biotechnology companies. Carmine also served as vice president of corporate development for Afraxis and co-founder and CEO of Araxes. Prior, he was with Phenomix Corporation as the senior director of business development and previously held positions of increasing responsibility at Anadys Pharmaceuticals and Johnson & Johnson Pharmaceutical Research and Development. Carmine currently serves on the boards of directors of Avelas Biosciences and Kiora Pharmaceuticals. He earned his MBA from the Johnson Graduate School of Management at Cornell University, M.S. in organic chemistry from Duke University and B.S. in chemistry from Wake Forest University.